Skip to main content

Advertisement

SpringerLink
Log in

Uterine Fibroid Causing Hyperprolactinemia and Paradoxical Prolactin Rise with Dopamine Agonist: Case Report and Systematic Review

  • Medicine
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Hyperprolactinemia in premenopausal women often presents with amenorrhea, symptoms of estrogen deficiency and sub-fertility. After exclusion of other common causes and in the context of a normal pituitary MRI scan, hyperprolactinemia is typically deemed “idiopathic.” Here we present a case where excess prolactin secretion was attributed to a uterine fibroid and following myomectomy the hyperprolactinemia and its clinical sequelae resolved. Following 6 years of secondary infertility, a 41-year-old woman presented with secondary amenorrhea, expressible galactorrhea, and symptoms of estrogen deficiency. Prolactin levels were consistently raised (1300 mU/L to 2100 mU/L, reference interval < 600 mU/L), and repeated pituitary imaging demonstrated no pituitary abnormality. Prolactin levels demonstrated a paradoxical rise in response to dopamine agonist therapy (2000 mU/L to 5900 mU/L). Imaging demonstrated a uterine fibroid and the patient underwent myomectomy. Following myomectomy, prolactin levels became undetectable, galactorrhea and symptoms of estrogen deficiency resolved, menses returned, and a planned unassisted pregnancy followed. Ectopic prolactin secretion from uterine fibroids is a rare cause of hyperprolactinemia and can result in the same clinical sequelae as pituitary causes. As ectopic prolactin secretion is not under inhibitory control of dopamine, it is usually resistant to, or may rise in response to, dopamine agonist therapy. Prior to a diagnosis of “idiopathic” hyperprolactinemia, ectopic sources of prolactin should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Horseman N, Gregerson K. Prolactin. In: Jameson J, De Groot L, editors. Endocrinology: adult and pediatric. 7th Edition: Saunders; 2017. p. 91–103.

  2. Sethi BK, Chanukya GV, Nagesh VS. Prolactin and cancer: has the orphan finally found a home? Indian J Endocrinol Metab. 2012;16:S195–8.

    Article  CAS  Google Scholar 

  3. Marano RJ, Ben-Jonathan N. Minireview: extrapituitary prolactin: an update on the distribution, regulation, and functions. Mol Endocrinol. 2014;28:622–33.

    Article  CAS  Google Scholar 

  4. Korytnaya E, Liu J, Camelo-Piragua S, Sullivan S, Auchus RJ, Barkan A. Ectopic prolactin secretion from a perivascular epithelioid cell tumor (PEComa). J Clin Endocrinol Metab. 2014;99:3960–4.

    Article  CAS  Google Scholar 

  5. Proust-Lemoine E, Mitchell V, Deruelle P, Lamblin A, Néraud B, Leroy X, et al. Ectopic hyperprolactinaemia in a woman with a mesocolic perivascular epithelioid cell tumor (“PEComa”). Ann Endocrinol (Paris). 2008;69(240–243).

  6. Gururaj S, Nisal K, Davies Q, Deen S, McNally PG. Ectopic prolactin secretion secondary to an ovarian tumour. Endocrinol Diabetes Metab Case Rep. 2013:130016.

  7. Hoffman WH, Gala RR, Kovacs K, Subramanian MG. Ectopic prolactin secretion from a gonadoblastoma. Cancer. 1987;60:2690–5.

    Article  CAS  Google Scholar 

  8. Elms AF, Carlan SJ, Rich AE, Cerezo L. Ovarian tumor-derived ectopic hyperprolactinemia. Pituitary. 2012;15:552–5.

    Article  Google Scholar 

  9. Nambiar KR, Nair SG, Devi RN. Acute myeloid leukemia presenting as galactorrhea. Proc (Bayl Univ Med Cent). 2016;29(395).

  10. Hatfill SJ, Kirby R, Hanley M, Rybicki E, Böhm L. Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4. Leuk Res. 1990;14:57–62.

    Article  CAS  Google Scholar 

  11. See WS, Cheuk DK, Fung KL, Chan GC. Acute lymphoblastic leukaemia presenting with galactorrhoea. BMJ Case Rep. 2013. https://doi.org/10.1136/bcr-2012-007461.

  12. Soroush AR, Zadeh HM, Moemeni M, Shakiba B, Elmi S. Plasma prolactin in patients with colorectal cancer. BMC Cancer. 2004;4:97.

    Article  CAS  Google Scholar 

  13. Bhatavdekar JM, Patel DD, Chikhlikar PR, Shah NG, Vora HH, Ghosh N, et al. Ectopic production of prolactin by colorectal adenocarcinoma. Dis Colon Rectum. 2001;44:119–27.

    Article  CAS  Google Scholar 

  14. Arbaiza D, Noriega K, Marcial J, Wachtel A, Perez C, Torres CF. Ectopic production of prolactin in an infant with non-Hodgkin lymphoma. Med Pediatr Oncol. 1999;32:311–2.

    Article  CAS  Google Scholar 

  15. Stanisic TH, Donovan J. Prolactin secreting renal cell carcinoma. J Urol. 1986;136:85–6.

    Article  CAS  Google Scholar 

  16. Quek ML, Soni RA, Hsu J, Skinner DG. Renal epithelioid angiomyolipoma associated with hyperprolactinemia. Urology. 2005;65:797.

    Article  Google Scholar 

  17. Hsu CT, Yu MH, Lee CY, Jong HL, Yeh MY. Ectopic production of prolactin in uterine cervical carcinoma. Gynecol Oncol. 1992;44:166–71.

    Article  CAS  Google Scholar 

  18. Turkington RW. Ectopic production of prolactin. N Engl J Med. 1971;285(26):1455–8.

    Article  CAS  Google Scholar 

  19. Herzog AG. Migraine with ectopic hyperprolactinemia from uterine fibroids. Neurology. 2000;55:148–9.

    Article  CAS  Google Scholar 

  20. Cordiano V. Complete remission of hyperprolactinemia and erythrocytosis after hysterectomy for a uterine fibroid in a woman with a previous diagnosis of prolactin-secreting pituitary microadenoma. Ann Hematol. 2005;84:200–2.

    Article  Google Scholar 

  21. Simsir IY, Kocabas GU, Sahin SB, Erdogan M, Cetinkalp S, Saygili F, et al. A case of an ectopic prolactinoma. Gynecol Endocrinol. 2012;28:148–9.

    Article  CAS  Google Scholar 

  22. Sato H, Asami Y, Shiro R, Yasuda M, Imai S, Sakai R, et al. Resolution of dopamine agonist-resistant hyperprolactinemia by hysterectomy: a case report. Gynecol Endocrinol. 2018;34:199–201.

    Article  Google Scholar 

  23. Power RF, Mani SK, Codina J, Conneely OM, O’Malley BW. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science. 1991;254:1636–9.

    Article  CAS  Google Scholar 

  24. Hiraoka Y, Tatsumi K, Shiozawa M, Aiso S, Fukasawa T, Yasuda K, et al. A placenta-specific 5′ non-coding exon of human prolactin. Mol Cell Endocrinol. 1991;75:71–80.

    Article  CAS  Google Scholar 

  25. Gellersen B, Kempf R, Telgmann R, DiMattia GE. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol. 1994;8:356–73.

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Rita Upreti

    Present address: Monash Health, Melbourne, Australia

Authors and Affiliations

  1. Department of Endocrinology, Waikato Hospital, Hamilton, New Zealand

    Rita Upreti

  2. Department of Anatomical Pathology, Waikato Hospital, Hamilton, New Zealand

    Michael Dray

  3. Waikato Clinical Campus, University of Auckland, Private Bag 3200, Hamilton, 3240, New Zealand

    Marianne S. Elston

Authors
  1. Rita Upreti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Dray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marianne S. Elston
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marianne S. Elston.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed were in accordance with the ethical standards of the National Health Advisory Committee’s Ethical Guidelines for Observational Studies and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Statement of Informed Consent

Written informed consent was given by the patient for investigation and publication.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Upreti, R., Dray, M. & Elston, M.S. Uterine Fibroid Causing Hyperprolactinemia and Paradoxical Prolactin Rise with Dopamine Agonist: Case Report and Systematic Review. SN Compr. Clin. Med. 2, 464–467 (2020). https://doi.org/10.1007/s42399-020-00248-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-020-00248-6

Keywords

Search

Navigation